SBH
FURX

Segall Bryant & Hamill’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Segall Bryant & Hamill’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25,326
Closed -$2.69M – 565
2014
Q2 		$2.69M Sell
25,326
-643
-2% -$63.1K 0.06% 235
2014
Q1 		$2.26M Sell
25,969
-196
-0.7% -$15.1K 0.05% 265
2013
Q4 		$1.1M Sell
26,165
-133
-0.5% -$5.47K 0.03% 327
2013
Q3 		$1.16M Buy
26,298
+29
+0.1% +$1.2K 0.03% 317
2013
Q2 		$895K Buy
+26,269
New +$922K 0.02% 313

Segall Bryant & Hamill's FURX Position: Q3 2014 in Review

Segall Bryant & Hamill sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 25,326 shares — an estimated $2.69M sold.

Segall Bryant & Hamill first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.69M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Segall Bryant & Hamill reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Segall Bryant & Hamill sold 25,326 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $2.69M.
  • Segall Bryant & Hamill first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Segall Bryant & Hamill's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.69M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Segall Bryant & Hamill's 13F filing for Q3 2014, filed 13 Nov 2014.